Clinical Trial Update: Effect of Obesity on Proton Pump Inhibitors [Phase 4]

View source ↗

Summary

Phase 4 trial completed evaluating whether obesity affects the use or effectiveness of proton pump inhibitors in obesity with NAFLD and GERD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease
• Non-alcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Proton Pump Inhibitors

Snippet

Sponsor: Children's Mercy Hospital Kansas City | Conditions: Pediatric Obesity, NAFLD | Phase 4 | Status: COMPLETED